Advertisement

Topics

Companies Related to "A Study to Determine the Relative Bioavailability of the MEK Inhibitor, Trametinib, in Subjects With Solid Tumor Malignancies" [Most Relevant Company Matches] RSS

05:17 EDT 20th October 2018 | BioPortfolio

Here are the most relevant search results for "A Study to Determine the Relative Bioavailability of the MEK Inhibitor, Trametinib, in Subjects With Solid Tumor Malignancies" found in our extensive corporate database of over 50,000 company records.

Showing "Study Determine Relative Bioavailability Inhibitor Trametinib Subjects With" Companies 1–25 of 995

Relevant

PharmaTech Solutions Inc

PTS was founded in 1999 by a group of pharmaceutical research professionals who believed that a pioneering approach was required to solve the industry’s study enrollment problems. Through innovation and excellence, PTS has amassed the technology and experience to develop patient recruitment solutions that identify and address the core issues that can hinder enrollment. PTS understands that findi...


Ardea Biosciences, Inc.

Ardea Biosciences, Inc., of San Diego, California, is a biotechnology company focused on the development of small-molecule therapeutics for the treatment of gout, cancer and human immunodeficiency virus (HIV). RDEA594, our lead product candidate for the treatment of hyperuricemia and gout, is a selective URAT1 transporter inhibitor in Phase 2 clinical development. Our next-generation URAT1 inhib...

CEL-SCI Corporation CEL-SCI Corporation

CEL-SCI's work is focused on finding the best way to activate the immune system to fight cancer and infectious diseases. Its lead investigational immunotherapy, Multikine* (Leukocyte Interleukin, Injection), is currently being studied in a pivotal Phase 3 clinical trial as a potential neoadjuvant treatment for patients with squamous cell carcinoma of the h...


Pharmacon Research GmbH

Pharmacon Research is an independent contract research organization (CRO) with headquarters in Berlin and clinical sites in Prague, Warsaw, Bratislava and Budapest. Founded in 1992 by the management of a successful Phase I unit, Pharmacon Research focuses on specific Phase I studies in patients and symptomatic subjects and on early Phase II studies (dose finding, proof of concept). Irrespective of...

International Pharmaceutical Research Center

International Pharmaceutical Research Center the commitment to unparalleled Quality Research. Our strength is our recognition from sponsors, investigators, and study subjects in conducting each study with dedication and a personal touch, while maintaining strict compliance with good clinical practice.

nTouch Research Corporation

nTouch Research Corporation is a leading provider of Phase II-IV clinical trials services delivering investigator selection, patient recruitment and study management services for pharmaceutical, CRO, and biotechnology industries.nTouch owns and operates 16 highly-rated research centers across the USA serving 250 private practice investigators. Our strength is our commitment to sponsors, investigat...

Arno Therapeutics, Inc.

Arno Therapeutics, Inc. is a clinical-stage biopharmaceutical company that develops and commercializes innovative products for the treatment of cancer patients. In addition to AR-67, Arno's lead clinical compound is AR-12, a potentially first-in-class, orally available PDK1 inhibitor that blocks the PI3K/Akt pathway and induces autophagy and the endoplasmi...

Roskilde University

Roskilde University is a state university founded in 1972 with the objective of providing research and education at the highest level in the fields of natural science, social science and the humanities. These activities at Roskilde University are organised in ten departments; degrees are offered in a wide range of subjects at Bachelor, Master and Ph.D. levels.Many study programmes are now being of...

DisperSol Technologies LLC

DisperSol is an innovator in the formulation development and manufacture of pharmaceutical drugs. DisperSol’s KinetiSol® technology has dramatically improved the effectiveness of drugs by superior enhancement of drug loading, solubility, permeability and bioavailability relative to other technologies. This has enabled the improvement of approved dr...

RWTH Aachen University

RWTH Aachen University,Here, you will discover numerous opportunities offered at this university in the areas of research, teaching and study.The RWTH Aachen is characterised by its strength in science and engineering education. It also provides a wide range of subjects in Economics, Arts and Humanities and Medicine with an emphasis on intensive interaction between all disciplines. The focus on in...

MedAvante, Inc.

MedAvante is the premier global provider of centralized expert psychiatric rating and monitoring services to the pharmaceutical, biotechnology and medical device industries. Our flagship service, Remote Centralized Ratings are real-time assessments, either by telephone or videoconference, of subjects in global drug trials. Centralizing the assessors and blinding them to study protocols, results in...

Shape Pharmaceuticals, Inc.

Shape Pharmaceuticals, Inc. is developing SHP-141, a novel, topical, “soft-drug” HDAC inhibitor for the treatment of patients with cutaneous T cell lymphoma (CTCL) and psoriasis. Shape has an ongoing Phase 1b clinical study in CTCL patients and has completed a Phase 1b clinical study in psoriasis patients. The development of SHP-141 is being supp...

Biothera

Biothera, a privately held U.S. biotechnology company, is developing Imprime PGG, a late clinical stage biologic that modulates the immune response to cancer. Data from the most recent randomized phase 2 study of Imprime PGG in first line non-squamous non-small cell lung cancer (NSCLC) was featured as a late-breaking abstract in the Immunotherapy of Cancer...

Providence Clinical Research (PCR)

Providence Clinical Research (PCR) promotes the highest quality clinical research in the community setting. We provide support, training, oversight and tools to ensure the success of established and new clinical investigators. We advocate for study subjects, maintain the highest professional standards, and enable investigative site excellence

BioTechNews Denmark

TopoTarget and CuraGen Announce Initiation of NCI-sponsored Phase II Clinical Trial with PXD101 for MesotheliomaTopoTarget A/S and CuraGen Corporation announced today the initiation of patient dosing in a Phase II clinical trial evaluating the activity of PXD101, a small molecule histone deacetylase (HDAC) inhibitor, for the treatment of mesothelioma. This trial is being sponsored by the National ...

Atlantic Life Sciences, Inc

Atlantic Life Sciences, Inc., Provider of Tailored Clinical Services ALS Inc. is located in Montreal.It is one of the world-class CRO where the Experience, the Expertise and the Strategic Project Management create a value addition for the study success. Since its inception, Atlantic Life Sciences Inc. accomplishes clinical studies with a top quality. Each study is unique. Since 2003, ALS Inc. cond...

Clinical Research Associate

Clinical Research Associate, also known as a Monitor, is an individual that oversees the progress and conduct of a clinical trial. A clinical trial is usually implemented by physicians at a hospital, clinic, or physician's office. The CRA is required to oversee the initiation, progress, and conduct of the clinical trial to ensure the scientific integrity of the data collected, and the protection o...

S*BIO Pte Ltd

S*BIO is a privately-held biotech company focused on the research and clinical development of novel targeted small molecule drugs for the treatment of cancer with leading programs around histone deacetylases (HDAC) and kinases. S*BIO's lead candidate, SB939, entered the clinic in 2007. SB1518, S*BIO's potent and orally-active JAK2 inhibitor, entered the clinic in 2008 and has received orphan drug ...

University of Münster

The University of Münster is the third largest in Germany. Currently, about 39,000 students are enrolled and every year about 5,000 are graduating.The university's popularity is no doubt due to the wide range of subjects on offer (over 120), the excellence of the research carried out in many departments, and the high quality of life in the city of Münster.Münster University has an international...

Charles University Prague Faculty of Pharmacy

The Faculty of Pharmacy, Charles University, with its seat in the town of Hradec Kralove, was established by a government decree in 1969. This Faculty of Pharmacy has continued in the old and long-time tradition of the education of pharmacy at Charles University - the Prague pharmacists were connected with Charles Univesity from its foundation. (The owners of Prague pharmacies were enrolled in the...

Goodwyn IRB

Goodwyn means "good friend" and The Goodwyn IRB® is a good friend to pharmaceutical manufacturers, contract research organizations, site management organizations and the human subjects involved in clinical research studies.Actually, The Goodwyn IRB is a unique group of good friends – experts from all over North America, chosen for their expertise and reputation to provide the highest level of r...

RealTime Laboratories, LLC

RealTime Laboratories, LLC (RTL) is a molecular biology and microbiology laboratory specializing in the detection of mycotoxins in human and environmental samples. RTL uses patented DNA testing to help patients and their physicians determine the effects of exposure to environmental toxins. To date, RTL has conducted the only peer reviewed and published research on the subject of contaminated drywa...

Acerta Pharma B.V.

Acerta is a leader in the field of covalent binding technology and is applying this technology to create novel selective therapies intended for the treatment of cancer and autoimmune diseases. Acerta’s lead molecule, acalabrutinib (ACP-196), is a selective and potent inhibitor of Btk. Acerta is also developing ACP-319, a novel selective inhibitor of P...

Rapid Medical Research, Inc.

Rapid Medical Research, Inc., (RMR) is a free-standing, dedicated, multi-therapeutic clinical research center. Our professional research team includes an executive director, two physicians including a full-time onsite internist and 1 part-time OB/GYN, a regulatory specialist, four nurse coordinators, two patient recruiters, two research assistants, and an office manager. We offer a wide range of s...

KalVista Pharmaceuticals, Inc.

KalVista Pharmaceuticals, Inc. is a pharmaceuticals company focused on the discovery, development, and commercialization of small molecule protease inhibitors for diseases with significant unmet need. The initial focus is on inhibitors of plasma kallikrein, which is an important component of the body’s inflammatory response and which, in excess, can l...


More From BioPortfolio on "A Study to Determine the Relative Bioavailability of the MEK Inhibitor, Trametinib, in Subjects With Solid Tumor Malignancies"

Advertisement
Quick Search
Advertisement
Advertisement

 

Corporate Database Quicklinks